“He knew we were getting antsy and he gave an update.”
This is not a good reason.
NP said the results would be released in mid-January and that aligned with wording in a PR. That was pushed to mid-February per the PR at the end of January. Now it’s late February and we get a PR saying that shareholders will get data in a few weeks once discussions with the FDA are complete? Discussions for what? If the primary endpoint was met, release it to shareholders and get the EUA process going. Again, doesn’t really make much sense.